What Uber's board member got wrong about men and women
David Bonderman resigned after saying women lead to "more talking" in meetings, but science disputes that
Watch CBS News
Aimee Picchi is associate managing editor for CBS MoneyWatch, where she covers business and personal finance. She previously worked at Bloomberg News and has been published by national news outlets including USA Today and Consumer Reports. Aimee frequently writes about retirement, and has been a National Press Foundation fellow for reporting on retirement and Columbia University's Age Boom Academy. She's also the editor of the Institutional Investor book "Cultivating the Affluent II," with noted wealth consultant Russ Alan Prince.
David Bonderman resigned after saying women lead to "more talking" in meetings, but science disputes that
Double-digit increases in health care costs may be a thing of the past, but medical inflation is still outpacing wage growth
Their surging college enrollment is a success story, but deep student debt and paltry pay can lead to financial struggles
Rural counties are leading the growth in pretrial detentions, even as big cities are seeking to reduce their jail sizes
The $70 billion ride-hailing company is said to be rethinking its corporate culture amid questions over its embattled CEO
The group's labor force participation has been on a 30-year slide, but it's not because the kids are getting lazier
The online retail giant is making a play for Walmart's core customer base with a discounted $6 per month Prime offer
The president's citation of the one-time steel town for leaving the Paris agreement ignores the city's massive changes
Rising fortunes for the global elite mean more money is chasing one-of-a-kind purchases -- and experiences
Although the president blames a "very bad" Germany for its trade imbalance with the U.S., other factors explain the gap
Global test ranks young Americans, teenagers from other countries in their understanding of money matters
Discounts given by private colleges are at an all-time high, with the average price break now just under 50 percent
That's a deeply debated notion, and surely, many Trump supporters depend on food stamps and disability benefits
Eli Lilly and Novo Nordisk are raising the cost of treatments even as the drugmakers face allegations of price collusion
Investors who held onto their Amazon shares would have made an enormous profit, although not without some bumps along the way